Safety of immune checkpoint inhibitors in patients with preexisting autoimmune disorders.

被引：0
|
作者：
Kumar, Rohit
Chan, Abigail Sy
Bandikatla, Sudeepthi
Mudra, Sarah
Ranjan, Smita
Ngo, Phuong
机构：
[1] Univ Louisville, James Brown Graham Canc Ctr, Div Hematol & Med Oncol, Louisville, KY 40292 USA
[2] Univ Louisville, Louisville, KY 40292 USA
[3] Univ Louisville Hosp, Louisville, KY USA
[4] Univ Louisville, Sch Med, Louisville, KY 40292 USA
[5] Univ Louisville, James Graham Brown Canc Ctr, Div Hematol & Med Oncol, Louisville, KY 40292 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e14568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14568
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Immune checkpoint inhibitors in Cancer patients with rheumatologic preexisting autoimmune diseases: a systematic review and meta-analysis
    Liu, Xin
    Li, Su
    Ke, Liyuan
    Cui, Hongxia
    BMC CANCER, 2024, 24 (01)
  • [22] Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease
    Liu, Michael
    Christ, Lisa
    Richters, Anke
    Ozdemir, Berna C.
    ONCOLOGY LETTERS, 2023, 26 (03)
  • [23] Use of Immune Checkpoint Inhibitors in the Treatment of Patients with Cancer and Preexisting Autoimmune Diseases: A Systematic Review of Case Reports
    Abdel-Wahab, Noha
    Shah, Mohsin
    Suarez-Almazor, Maria
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [24] Immune checkpoint inhibitors therapies in patients with cancer and preexisting autoimmune diseases: A meta-analysis of observational studies
    Xie, Wenhui
    Huang, Hong
    Xiao, Shiyu
    Fan, Yong
    Deng, Xuerong
    Zhang, Zhuoli
    AUTOIMMUNITY REVIEWS, 2020, 19 (12)
  • [25] A retrospective analysis of immune checkpoint inhibitors in patients with preexisting organ dysfunction
    Kesireddy, Meghana
    Marr, Alissa
    Schissel, Makayla
    Ganti, Apar K.
    CANCER, 2023, 129 (22) : 3603 - 3619
  • [26] Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease
    Alexander, Swetha
    Swami, Umang
    Kaur, Aneet
    Gao, Yubo
    Fatima, Munazza
    Ginn, Meredith M.
    Stein, Jill E.
    Grivas, Petros
    Zakharia, Yousef
    Singh, Namrata
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (12)
  • [27] Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease RESPONSE
    van der Kooij, Monique K.
    Suijkerbuijk, Karijn P. M.
    Dekkers, Olaf M.
    Kapiteijn, Ellen
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (09) : 1345 - 1346
  • [28] SAFETY AND EFFICACY FOLLOWING IMMUNE CHECKPOINT INHIBITORS THERAPIES IN PATIENTS WITH CANCER AND PREEXISTING AUTOIMMUNE DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
    Xie, Wenhui
    Huang, Hong
    Xiao, Shiyu
    Zhang, Zhuoli
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 5 - 5
  • [29] Effectiveness and Safety of Immune Checkpoint Inhibitors in Cancer Patients With Autoimmune Disease: A Retrospective Cohort Study
    Raghavan, Arjun
    Goutam, Sid
    Musto, Grace
    Geirnaert, Marc
    Ye, Carrie
    O'Neil, Liam
    Graham, Jeffrey
    JOURNAL OF IMMUNOTHERAPY, 2024, 47 (01) : 1 - 6
  • [30] Safety of Immune Checkpoint Inhibitors in Patients Treated for Cancer with Pre-existing Autoimmune Diseases
    Kaur, Aneet
    Swami, Umang
    Fatima, Munazza
    Ginn, Meredith
    Stein, Jill
    Gao, Yubo
    Zakharia, Yousef
    Singh, Namrata
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345